top of page

European Medicines Agency decision on the refusal of a product specific waiver for 18F fluoromisonid

A waiver for 18F fluoromisonidazole, solution for injection, intravenous use, the details of which are set

out in the opinion of the Paediatric Committee of the European Medicines Agency annexed hereto,

together with its appendices, is hereby refused.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page